India, May 23 -- Shares of GeoVax Labs, Inc. (GOVX) are surging over 30% on Monday morning. The stock is currently trading at $1.8138, up $0.4238 or 30.4892%, on the Nasdaq.
Analysts at Maxim Group re-affirmed its "buy" rating for GeoVax Labs. They now have a $6.00 price target on the stock.
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....